FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Heparin sodium 25,000iu/mL injection solution 1mL ampule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Heparin calcium 25,000iu/mL injection solution 0.2mL ampule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Heparin calcium 25,000iu/mL injection solution 0.2mL prefilled syringe VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 25,000iu/mL injection solution 0.2mL ampule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluticasone propionate 25micrograms inhaler VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Squill opiate pediatric linctus VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Trifluoperazine 2mg m/r capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely doxepin (as doxepin hydrochloride) 25 milligram/1 each conventional release oral capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely doxepin (as doxepin hydrochloride) 50 milligram/1 each conventional release oral capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pentazocine 30mg/mL injection solution 2mL ampule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely piracetam 1.2 gram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely ampicillin (as ampicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely griseofulvin 125 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely griseofulvin 500 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely levonorgestrel 750 microgram/1 each conventional release oral tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely azapropazone 300 milligram/1 each conventional release oral capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium hyaluronate 15mg/mL injection solution 2mL prefilled syringe VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Hydroxypropyl methylcellulose 0.32% single-use eye drops VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Rose bengal 1% single-use eye drops VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release nasal spray VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour patch VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour patch VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour patch VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour patch VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Typhoid vaccine e/c capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Potassium chloride 10mmol/glucose 5% infusion solution 500mL bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely telithromycin 400 milligram/1 each conventional release oral tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Gemcitabine 1g/26.3ml concentrate for solution for infusion vials (Consilient Health Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gemcitabine 2g/52.6ml concentrate for solution for infusion vials (Consilient Health Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gemcitabine 1g/26.3ml concentrate for solution for infusion vials (Consilient Health Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gemcitabine 2g/52.6ml concentrate for solution for infusion vials (Consilient Health Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Dermablend cover creme VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic XMet Homidon powder VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Insulin isophane biphasic human 10/90 100units/ml suspension for injection 1.5ml cartridges VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Insulin isophane biphasic human 20/80 100units/ml suspension for injection 1.5ml cartridges VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Insulin isophane biphasic human 40/60 100units/ml suspension for injection 1.5ml cartridges VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Insulin isophane biphasic human 50/50 100units/ml suspension for injection 1.5ml cartridges VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Insulin isophane bovine 100units/ml suspension for injection 1.5ml cartridges VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Insulin soluble porcine 100units/ml suspension for injection 1.5ml cartridges VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Metatarsal arch supports VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Pepdite powder VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1ml solution for injection ampoules (Wockhardt UK Ltd) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Pregestimil powder VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Resource Protein Extra liquid VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1ml solution for injection ampoules (Wockhardt UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mebeverine 50mg/5ml oral suspension sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aciclovir 3% eye ointment VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Simeticone 100mg capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Strepsils Menthol and Eucalyptus lozenges VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ganciclovir 0.15% eye gel VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dichlorobenzyl alcohol 1.2mg / Amylmetacresol 0.6mg lozenges sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium bicarbonate 8.4% solution for injection 100ml bottles VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Vivioptal capsules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium hypochlorite 2% solution VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Boots Migraine Pain Relief Ibuprofen lysine 342mg tablets (The Boots Company Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1ml solution for injection ampoules 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucosamine sulphate 600mg tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1ml solution for injection ampoules (Aspire Pharma Ltd) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Boots Migraine Pain Relief Ibuprofen lysine 342mg tablets (The Boots Company Plc) 12 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1ml solution for injection ampoules (Aspire Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Follitropin beta 300units/0.36ml solution for injection cartridges VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Bio-Kult Infantis oral powder 1g sachets sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ibuprofen lysine 200mg tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Furosemide 40mg / Potassium 8mmol modified-release tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Paracetamol 1g oral powder sachets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Gentamicin 5mg/1ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Silver nitrate 40% caustic pencils VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefalexin 125mg/5ml oral suspension sugar free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium lactate compound (Hartmann's Solution) infusion 500ml polyethylene bottles VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Bio-Kult Infantis oral powder 1g sachets sugar free 16 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bio-Kult Infantis oral powder 1g sachets sugar free (ADM Protexin Ltd) 16 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bio-Kult Infantis oral powder 1g sachets sugar free (ADM Protexin Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levobupivacaine 125mg/200ml infusion bags VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 1mg tablets and Varenicline 500microgram tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 500microgram tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 1mg tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix titration pack (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Pfizer Ltd) 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 1mg tablets 14 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix titration pack (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levobupivacaine 125mg/200ml infusion bags 5 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chirocaine 125mg/200ml solution for injection bags (Abbott Laboratories Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levobupivacaine 125mg/200ml infusion bags (Fresenius Kabi Ltd) 5 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 500microgram tablets 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Mawdsley-Brooks & Company Ltd) 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 500microgram tablets (Imported (Canada)) 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 1mg tablets and Varenicline 500microgram tablets (Imported (Canada)) 25 tablet 1 x (11 tablets + 14 tablets) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Pfizer Ltd) 14 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chirocaine 125mg/200ml solution for injection bags (Abbott Laboratories Ltd) 12 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 1mg tablets (Waymade Healthcare Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix titration pack (Waymade Healthcare Plc) 25 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Varenicline 1mg tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Champix 0.5mg tablets (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 21 of 86 Next End

This concept is not in any reference sets

Back to Start